General Information
Call for Abstracts
Call for abstracts of Foreign Invited Speakers
Early Registration
Medical / Morning / Evening / Seminar
Information for Paticipants
Information for Chairs and Speakers
ESMO ASIA - Call for abstract
ESMO ASIA - Early Registration
ESMO ASIA - Late Registration
Feel KOBE + Discovering the Joy of Kobe
Call for Abstracts
Abstract submission period
Call for abstracts
Late-breaking abstracts
Plenary Session
Travel Award
Publication in “Annals of Oncology”
Disclosure of Conflict of Interest at the Japanese Society of Medical Oncology 2018 Annual Meeting
Abstract Submission
Confirmation / Modification / Deletion of submitted abstract / Additional submission
Acceptance/rejection notification
Abstract Submission / Confirmation / Modification / Deletion of submitted abstract / Additional submission
Inquiry (Technical problems / questions)
  Abstract Submission Period
Call for Abstracts has closed.
Abstract submission opens: Friday, December 15, 2017
Abstract submission deadline: Thursday, March 1, 2018 at noon JST
  Thursday, March 8, 2018 at noon JST
  Thursday, March 14, 2018 at noon JST
  Call for Abstracts
Free paper (Oral / Poster Presentation)
  JSMO2018 accepts abstracts for free paper.
Presentation style will be either Oral or Poster presentation.
Please select the abstract category from the list below. (The 1st & 2nd choices are required.)
Abstract Category for Free Paper  
1 - 32 Biostatistics
2 Pediatric malignancy 33 Regulatory science
3 Brain tumors 34 Clinical trial support
4 Head and neck cancer 35 Molecular-targeted drug
5 Breast cancer 36 Cytotoxic drug
6 Esophageal cancer 37 Immunotherapy
7 Gastric cancer 38 Other anti-cancer drugs
8 Colorectal cancer 39 Pharmaceutical science
9 Hepatoma / HCC 40 Big data
10 Biliary tract cancer / Pancreatic cancer 41 Trials in progress (a)
11 Lung cancer 42 Molecular and genetic diagnosis
12 Uterin cancer / Ovarian cancer 43 Companion diagnostics
13 Other gynecological cancer 44 Diagnostic imaging
14 Urologic cancer 45 Other diagnostics
15 Endocrine tumors / Thyroid cancer 46 Supportive care
16 Skin cancer 47 Palliative medicine
17 Bone and soft tissue tumors 48 Regional medical network
18 Lymphoma 49 Team medical care
19 Leukemia 50 Rehabilitation
20 Other hematological malignancies 51 Outpatient chemotherapy
21 Cancer of unknown primary 52 -
22 Neuroendocrine tumors 53 -
23 Hereditary neoplasm 54 Oncology nursing
24 Therapeutic radiology 55 Oral care
25 Basic research 56 Patient advocacy / Cancer survivorship
26 Immunology 57 Adolescent and Young Adult Oncology
27 Cancer epigenetics 58 Geriatric Oncology
28 Translational research 59 Healthcare economics
29 Innovative drug research & development 60 Case reports
30 Early clinical development 61 Others
31 Clinical pharmacology  
(a) Please note that if you select “Trials in Progress,” your abstract will NOT be included in the JSMO2018 USB abstract or any other available electronic program, such as “My schedule.” Your submitted abstracts will be printed and handed out to the participants at the room where you deliver your presentation.
* Abstract Encouragement Award
  Age limitation: The first author must be under the age 40 (as of July 21, 2018)
  Once you are nominated as a candidate, you will be requested to submit an electronic data for review in May, 2018.
  If you would like to be reviewed as a candidate, please check the box to be reviewed as the candidate for the Abstract Encouragement Award.
* All submitted abstracts will be reviewed by the Peer Review Committee and decided comprenensively based on the study contents, ethical aspects, and etc. You may choose the presentation style (oral or poster) when you submit an abstract. However, please understand that the congress president will make a final decision on the presentation style, presentation session, as well as acceptance/rejection.
  Late-breaking abstracts
JSMO2018 would like to deepen discussions based on the latest research results. We accept such abstracts as "Late-breaking abstracts".
If you are applying for Late-breaking abstracts, please select “Yes” for the question, “Are you applying for late-breaking abstracts?” and submit an outline and predicted results of your research as interim registration in the abstract text box.
Please complete the abstract submission with the latest research results by Friday, April 13, 2018.(You will be notified by the Secretariat to complete the abstract submission at the beginning of April.)
* Your abstract may not be included in the JSMO2018 USB Abstract if the complete abstract is submitted later than Friday, April 13.
  Plenary Session (International Session)
JSMO2018 will select the abstracts for “Plenary Sessions” from the submitted abstracts.
  Travel Award
Abstracts submitted by young researchers from outside Japan will be reviewed by the JSMO2018 committee members. Those selected presenters will be awarded partial travel grant for their outstanding works.
The award details are as follows:
* JPY50,000-100,000 of travel support to investigators from Asia. (depending on the quality of abstract)
* JPY150,000 of travel support to investigators from US or EU.
Note:  To qualify for the travel award, you must be free of any commercial grant or support.
  Publication in “Annals of Oncology”
Abstracts (oral/ poster) submitted in English for JSMO2018 Annual Meeting will be published in ESMO/JSMO Scientific Journal, supplement to “Annals of Oncology” (Oxford University Press).
If you wish to have your abstract published in “Annals of Oncology,” please select “Yes”.
* Terms to be published in Journal "Annals of Oncology" as to poster presentation:
(1) Your abstract must be accepted for poster presentation.
(2) To be published in the Journal “Annals of Oncology,” the posting fee (5,000JPY) must be paid in addition to the Congress registration fee.
Secretariat will contact you once your abstract is accepted as poster presentation.
  Disclosure of Conflict of Interest at the Japanese Society of
Medical Oncology 2018 Annual Meeting
The first authors and directors (who are in charge of the studies, usually last author) must disclose applicable COI (Conflict of Interest) of your presentation at the meeting. Please inform the COI from January 1, 2015 to December 31, 2017.
COI Disclosure Information
COI policy
Detailed Enforcement regulations of COI
  To view the PDF files, you may need, “Adobe Reader”
(Download Adobe Reader
For oral presentation, please use the slide below as a template to disclose conflict of interest.
For poster presentation, please prepare and print out the slide, and put it at lower right of the poster panel.
Template of slide(302KB)
Questions regarding COI disclosure
  The Secretariat of the Japan Society of Medical Oncology
  Abstract Submission
We accept abstracts submitted online only through the submission system.
You may enter the submission page from “Abstract Submission” button at the bottom of this page.
(1) Author information and abstracts must be submitted in English.
(2) Abstract title must be up to 120 single-byte characters.
(3) Abstract text must be up to 2,000 single-byte characters.
(4) The maximum of 15 authors (first author & co-authors) can be registered.
(5) The maximum of 15 affiliations (including the affiliation of the first author) can be registered.
(6) Please structure your abstract as follows:
(7) Any chart or diagram cannot be included.
(8) Regarding the special characters, please refer here.
(9) In the registration page, you will be asked to enter the information such as
“application for Late-breaking abstracts”, “application for Travel Award”, “Publication in Annals of Oncology” as well as COI information.
* It is recommended that you prepare your abstract text by Word/ text file in advance, and then copy it on the registration page.
* After completing the abstract submission, the abstract registration ID number and your password will be sent to the first author’s email address. The ID number and password will be required to confirm/modify/delete/add abstracts. Please be sure to enter the correct e-mail address. Please be sure to keep the ID number and password by yourself. The congress secretariat will NOT keep track of your information.
  Confirmation / Modification / Deletion of Submitted Abstract &
Additional Submission
  You can access to confirm/modify/delete/add abstracts during the abstract submission period.
The ID number and password will be required to enter the page (confirm/modify/delete/add abstracts).
  Acceptance/Rejection Notification
  Notification of acceptance/rejection will be sent to the first author by email by May, 2018.
  Abstract Submission
  Confirmation / Modification / Deletion of submitted abstract &
Additional submission
  Inquiries for Abstract Submission
  Congress Secretariat
c/o Congress Corporation
1-9-17 Tenjin Chuo-ku, Fukuoka, Japan
Phone: +81-92-716-7116 Fax: +81-92-716-7143
E-mail: jsmo2018@congre.co.jp
  Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University
3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
  c/o Congress Corporation
1-9-17 Tenjin Chuo-ku, Fukuoka, Japan
Phone: +81-92-716-7116
Fax: +81-92-716-7143
E-mail: jsmo2018@congre.co.jp
Copyright© 2018 The Japanese Society of Medical Oncology Annual Meeting All Rights Reserved.